BeStock  
Stocks › Biotechnology › VSTM

Verastem VSTM

US equityMarket cap rank #3463Biotechnology
$8.27 +$0.52 (+6.65%)
Pre-market · Oct 8, 6:50 am ET · After hours $8.27 0.00%
Open$7.77
Prev close$7.75
Day range$7.65 – $8.36
Volume3.93M
Market cap$748.51M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$40.08M+1,775.4% YoY
Operating profit-$32.71M+25.3% YoY
Net profit-$34.67M-33.7% YoY
Diluted EPS-$0.35+43.5% YoY
Free cash flow-$43.91M-34.4% YoY
Operating cash flow-$43.91M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$2.1MJun '25$11.2MSep '25$17.5MDec '25$18.7MMar '26$40.1MJun '26

Net profit, last 8 quarters

$-24.0MSep '24$-64.6MDec '24$-52.1MMar '25$-25.9MJun '25$-98.5MSep '25$-32.9MDec '25$-36.6MMar '26$-34.7MJun '26

Diluted EPS by quarter

-0.60Sep '24-1.55Dec '24-0.96Mar '25-0.62Jun '25-1.35Sep '25-0.29Dec '25-0.46Mar '26-0.35Jun '26

Free cash flow by quarter

$-23.8MSep '24$-25.1MDec '24$-38.7MMar '25$-32.7MJun '25$-44.5MSep '25$-31.3MDec '25$-52.1MMar '26$-43.9MJun '26

Annual revenue

$88.5MFY20$2.1MFY21$2.6MFY22$0.0FY23$10.0MFY24$30.9MFY25

Profitability & balance sheet

Gross margin86.4%
Operating margin-182.6%
Net margin-231.6%
Return on equity-471.2%
Return on assets-100.7%
Return on invested capital-160.4%
Current ratio2.25
Liabilities / assets75.8%
Cash & investments$136.35M
Total debt$83.84M
Net cash (debt)$52.52M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $40.08M $18.67M $30.91M $17.54M $11.24M
Total Operating Revenue $40.08M $18.67M $30.91M $17.54M $11.24M
Cost of Revenue $4.04M $3.05M $5.30M $2.89M $1.96M
Gross Profit $36.04M $15.62M $25.62M $14.64M $9.28M
Operating Expense $68.75M $60.52M $195.75M $56.12M $50.00M
Selling and Admin Expenses $27.41M $22.30M $81.15M $24.44M $21.01M
Research & Development $41.34M $38.22M $114.60M $31.67M $28.99M
Operating Profit -$32.71M -$44.90M -$170.13M -$41.48M -$40.72M
Net Non-Operating Interest Income (Expense) $748,000.00 $915,000.00 $2.93M $689,000.00 $863,000.00
Non-Operating Interest Income $1.11M $1.30M $4.07M $1.10M $1.18M
Non-Operating Interest Expense $360,000.00 $382,000.00 $1.14M $415,000.00 $319,000.00
Other Income (Expense) -$1.90M $7.39M -$42.27M $7.87M -$58.67M
Special Income (Charges) $0.00 $0.00 -$1.83M $0.00 $0.00
Other Non-Operating Income (Expenses) -$1.90M -$1.93M -$12.95M -$2.62M -$2.79M
Pretax Profit -$33.86M -$36.59M -$209.47M -$32.92M -$98.52M
Tax $816,000.00 – $0.00 – –
Net Profit -$34.67M -$36.59M -$209.47M -$32.92M -$98.52M
Profit from Continuing Operations -$34.67M -$36.59M -$209.47M -$32.92M -$98.52M
Net Income to Parent Company -$34.67M -$36.59M -$209.47M -$32.92M -$98.52M
Net Income to Common Stockholders -$34.67M -$36.59M -$209.47M -$32.92M -$98.52M
Basic EPS -$0.35 -$0.37 -$3.02 -$0.29 -$1.35
Diluted EPS -$0.35 -$0.46 -$3.02 -$0.29 -$1.35
Gain on Sale of Security – $9.32M -$27.49M $10.49M -$55.88M
-Less:Other Special Charges – – $1.83M $0.00 –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $206.51M $227.81M $246.44M $246.44M $176.85M
Total Current Assets $176.16M $202.90M $223.41M $223.41M $154.06M
Cash and Cash Equivalents & Short-Term Investments $136.35M $181.68M $213.80M $213.80M $137.71M
-Cash and Cash Equivalents $136.35M $165.55M $204.99M $204.99M $137.71M
Receivables $29.07M $10.36M $200,000.00 $200,000.00 $6.92M
-Accounts Receivable $28.87M $10.16M – – $6.72M
-Other Receivables $200,000.00 $200,000.00 $200,000.00 $200,000.00 $200,000.00
Inventory $2.40M $2.29M $1.83M $1.83M $1.79M
Other Current Assets $8.33M $8.58M $7.58M $7.58M $7.64M
Total Non-Current Assets $30.36M $24.90M $23.03M $23.03M $22.80M
Net PPE $2.63M $2.79M $491,000.00 $491,000.00 $750,000.00
-Gross PPE $2.63M $2.79M $2.11M $2.11M $750,000.00
Goodwill and Other Intangible Assets $15.87M $16.15M $16.43M $16.43M $16.71M
-Other Intangible Assets $15.87M $16.15M $16.43M $16.43M $16.71M
Other Non-Current Assets $11.86M $5.97M $6.11M $6.11M $5.34M
Total Liabilities $156.53M $146.03M $189.25M $189.25M $192.38M
Total Current Liabilities $78.13M $66.85M $72.27M $72.27M $59.71M
Payables $18.00M $9.60M $12.45M $12.45M $9.89M
-Accounts Payable $18.00M $9.60M $12.45M $12.45M $9.89M
Current Accrued Expenses $47.56M $43.04M $43.12M $43.12M $36.91M
Short-Term Debt and Capital Lease Obligation $5.94M $6.29M $5.84M $5.84M $5.10M
-Current Debt $5.44M $5.80M $5.30M $5.30M $4.31M
-Current Capital Lease Obligation $493,000.00 $494,000.00 $535,000.00 $535,000.00 $793,000.00
Total Non-Current Liabilities $78.40M $79.19M $116.98M $116.98M $132.67M
Long Term Debt and Capital Lease Obligation $78.40M $79.19M $81.33M $81.33M $84.37M
-Long Term Debt $76.27M $76.87M $81.33M $81.33M $84.37M
-Long Term Capital Lease Obligation $2.12M $2.32M $0.00 $0.00 $0.00
Derivative Product Liabilities $0.00 $0.00 $35.65M $35.65M $48.29M
Total Equity $49.99M $81.78M $57.20M $57.20M -$15.53M
Stockholders' Equity $49.99M $81.78M $57.20M $57.20M -$15.53M
Capital Stock $9,000.00 $9,000.00 $8,000.00 $8,000.00 $7,000.00
-Common Stock $9,000.00 $9,000.00 $8,000.00 $8,000.00 $7,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 –
Additional Paid-In Capital $1.28B $1.27B $1.22B $1.22B $1.11B
Retained Earnings -$1.24B -$1.20B -$1.16B -$1.16B -$1.13B
Gains/Losses Not Affecting Retained Earnings $8.04M $8.62M $5.23M $5.23M $2.55M
-Short Term Investments – $16.13M $8.81M $8.81M –
-Accumulated Depreciation – – -$1.62M -$1.62M –
Convertible preferred securities – – $0.00 $0.00 $0.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$43.91M -$52.12M -$137.51M -$29.95M -$36.22M
Net cash flow from continuing operations -$43.91M -$52.12M -$137.51M -$29.95M -$36.22M
Net Income from Continuing Operations -$34.67M -$36.59M -$209.47M -$32.92M -$98.52M
Gain/Loss from Continuing Operations $0.00 -$9.32M $29.32M -$10.49M $55.88M
Depreciation & Depletion & Amortization $280,000.00 $279,000.00 $728,000.00 $298,000.00 $292,000.00
Other Non-Cash Items -$72,000.00 $40,000.00 $6.51M $871,000.00 $1.09M
Change in Working Capital -$12.87M -$8.57M $26.00M $10.25M $2.86M
-Change in Receivables -$18.72M -$1.35M -$8.81M -$2.10M -$4.64M
-Change in Inventory -$109,000.00 -$454,000.00 -$1.83M -$39,000.00 -$626,000.00
-Change in Prepaid Assets -$5.65M -$857,000.00 -$2.61M -$707,000.00 -$1.10M
-Change in Payables and Accrued Expense $11.60M -$5.91M $39.26M $13.10M $9.23M
Net cash flow from investing $16.25M -$16.02M -$9.62M -$1.35M -$8.28M
Net Cash Flow from Continuing Investing Activities $16.25M -$16.02M -$9.62M -$1.35M -$8.28M
Net Investment Purchase and Sale $16.25M -$16.02M $0.00 $0.00 $0.00
Financing Cash Flow -$1.54M $28.69M $263.31M $98.58M $17.88M
Net Cash Flow from Continuing Financing Activities -$1.54M $28.69M $263.31M $98.58M $17.88M
Net Issuance Payments Of Debt $0.00 $0.00 $32.42M $1,000.00 $0.00
Net Common Stock Issuance $0.00 $0.00 $196.98M $96.88M $0.00
Proceeds from Stock Option Exercised $26,000.00 $29.41M $33.91M $1.89M $18.16M
Net Other Financing Charges -$1.57M -$721,000.00 – – -$278,000.00
Ending Cash Balance $136.59M $165.79M $205.23M $205.23M $137.95M
Net Change in Cash -$29.20M -$39.44M $116.17M $67.28M -$26.62M
Beginning Cash Balance $165.79M $205.23M $89.06M $137.95M $164.56M
Free Cash Flow -$43.91M -$52.12M -$147.13M -$31.30M -$44.50M
Net PPE Purchase and Sale – – $0.00 $0.00 –
Net Intangibles Purchase and Sale – – -$9.62M -$1.35M –
Net Preferred Stock Issuance – – $0.00 – –

Discussion

No comments yet — be the first to weigh in on VSTM.

Leave a comment

Scroll to Top